Clinical Scorecard: Comparative Analysis of Thulium Fiber and Holmium: YAG Lasers in Urology: Findings from the FDA MAUDE Database

At a Glance

Key Highlights

• TFL shows higher fiber break rates but fewer patient adverse events compared to Ho: YAG lasers.
• Ho: YAG lasers have more device malfunctions and patient events, with mostly minor (Gupta Level I) adverse events.
• FDA recall of TFL devices in 2021 led to significant reduction in patient harm and fiber breakages.

Guideline-Based Recommendations

Diagnosis

• Utilize MAUDE database surveillance to identify device-related adverse events in urologic laser procedures.

Management

• Apply FDA safety updates and software modifications post-recall to reduce thermal injury risks with TFL devices.
• Consider pulse modulation settings (e.g., MOSES) to balance fiber break rates and procedure cancellations in Ho: YAG lasers.

Monitoring & Follow-up

• Ongoing post-market surveillance of laser devices for device malfunctions and patient adverse events.
• Monitor severity of adverse events using Gupta classification to guide clinical response.

Risks

• Device malfunctions including console errors, overheating, and fiber breaks.
• Patient risks including minor to severe adverse events such as thermal injury and, rarely, fatal complications.
• Procedure cancellations more frequent with certain pulse modulation settings.

Patient & Prescribing Data

Patients undergoing urologic laser procedures including lithotripsy and prostate treatments

TFL devices post-FDA recall demonstrate improved safety profiles with fewer patient harms; Ho: YAG lasers remain effective but have higher device malfunction rates.

Clinical Best Practices

• Adhere to manufacturer power presets and updated safety protocols, especially for TFL devices.
• Employ pulse modulation techniques judiciously to minimize fiber breakage and procedure cancellations.
• Classify and grade adverse events using standardized systems (e.g., Gupta classification) for consistent reporting and management.
• Incorporate MAUDE database findings into clinical decision-making to enhance patient safety.

References

• FDA MAUDE Database
• FDA Class II Recall for Soltive Premium and Soltive Pro Super Pulsed Laser Systems
• Gupta Classification System for Adverse Events